| Date Filed | Type | Description |
| 08/08/2023 |
4
| SOOD NITIN (Chief Commercial Officer, MRD) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,652 shares
@ $6.78, valued at
$38.3k
Sold 10,550 shares
@ $6.54, valued at
$69k
|
|
| 06/06/2023 |
4
| PETERSON TYCHO (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 38,000 shares
@ $7.16, valued at
$272.1k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Pellini Michael J (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| OWEN KATEY EINTERZ (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| NEUPERT PETER M (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| Trigg Leslie (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| PISKEL KYLE (Principal Accounting Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 43,735 shares
@ $0
Sold 3,300 shares
@ $8.57, valued at
$28.3k
Sold 229 shares
@ $8.58, valued at
$2k
|
|
| 03/08/2023 |
4
| LO FRANCIS (Chief People Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 85,697 shares
@ $0
Sold 6,816 shares
@ $8.57, valued at
$58.4k
Granted 128,599 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| Taylor Stacy L (SVP and General Counsel) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 85,697 shares
@ $0
Sold 5,491 shares
@ $8.57, valued at
$47.1k
Sold 13,387 shares
@ $8.6, valued at
$115.1k
Granted 128,599 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 88,652 shares
@ $0
Sold 6,529 shares
@ $8.57, valued at
$56k
Sold 17,155 shares
@ $8.6, valued at
$147.5k
Granted 133,033 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| PETERSON TYCHO (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 118,203 shares
@ $0
Granted 177,377 options to buy
@ $8.46, valued at
$1.5M
|
|
| 03/08/2023 |
4
| BENZENO SHARON (Chief Commercial Ofc Imm Med) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 11,749 shares
@ $8.57, valued at
$100.7k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| SOOD NITIN (Chief Commercial Officer, MRD) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 6,661 shares
@ $8.57, valued at
$57.1k
Sold 9,813 shares
@ $8.6, valued at
$84.4k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| RUBINSTEIN JULIE (President) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 22,668 shares
@ $8.57, valued at
$194.3k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 03/08/2023 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 995 shares
@ $8.5, valued at
$8.5k
Sold 2,130 shares
@ $8.58, valued at
$18.3k
|
|
| 11/17/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 841 shares
@ $7.61, valued at
$6.4k
Sold 2,284 shares
@ $7.13, valued at
$16.3k
|
|
| 08/05/2022 |
4
| SOOD NITIN (Chief Commercial Officer, MRD) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 17,540 shares
@ $10.98, valued at
$192.6k
|
|
| 07/08/2022 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 825 shares
@ $9.53, valued at
$7.9k
Sold 2,300 shares
@ $10.47, valued at
$24.1k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/08/2022 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 831 shares
@ $13.17, valued at
$10.9k
|
|
| 03/10/2022 |
4
| Taylor Stacy L (SVP and General Counsel) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 2,387 shares
@ $11.44, valued at
$27.3k
|
|
| 03/10/2022 |
4
| BALDO LANCE (Chief Medical Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,350 shares
@ $11.43, valued at
$38.3k
|
|
| 03/10/2022 |
4
| LO FRANCIS (Chief People Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,582 shares
@ $11.44, valued at
$41k
|
|
|